| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |